Carboxychromanate-2-Ethyl-6-Methyl-3-Hydroxypyridine Increases the Body’s Resistance to Hypoxia

Measurement Techniques · Springer Nature · 2026-06-01 · DOI: 10.1134/S0006350926700466

Аннотация

Abstract The antiradical properties and biological activity of carboxychromate-2-ethyl-6-methyl-3-hydroxypyridine, a derivative of 3-hydroxypyridine, have been studied. The data obtained indicate the high antiradical activity of this drug and its ability to inhibit lipid peroxidation processes. At a concentration of 10 –9 M, carboxychromate-2-ethyl-6-methyl-3-hydroxypyridine prevented the activation of lipid peroxidation in the mitochondrial membranes of mouse liver, which suggests that it has adaptogenic properties. To test this assumption, a model of acute hypobaric hypoxia was used. Hypoxia caused a 3.5‑fold increase in the intensity of lipid peroxidation, accompanied by a decrease in the content of unsaturated C 18 fatty acids in the mitochondrial membranes. It was assumed that carboxychromate-2-ethyl-6-methyl-3-hydroxypyridine prevented mitochondrial dysfunction by inhibiting the oxidation of unsaturated C 18 fatty acids, particularly linoleic acid. This ensured the maintenance of a high level of energy metabolism in cells and manifested itself in increased stress resistance in mice and plant organisms.

Читать у издателя →

Похожие статьи